Senior Medical Science Liaison (Nephrology)

Responsibilities

• Serve as a scientific liaison to the medical and academic community, establishing and maintaining relationships with Nephrology Thought Leaders and Healthcare Providers.
• Disseminate clinical and scientific information regarding Vertex compounds in a timely, ethical, and stakeholder-focused manner.
• Contribute to the design and execution of Medical Affairs strategies by providing external stakeholder insights to shape medical plans.
• Engage HCPs in response to scientific educational and research needs using available Vertex resources.
• Utilize CRM and data analytics tools to capture interaction details and manage territory planning.
• Represent Vertex at medical congresses through scientific session coverage, booth staffing, and delivering conference debriefs.
• Assist clinical development and operations by presenting Investigator Brochure (IB) material and providing trial site nominations.

Requirements

• Advanced biomedical or life sciences degree (e.g., Masters, NP, PA).
• Minimum of 4 years of experience as an MSL supporting Nephrology programs or in other medical affairs roles within the pharma/biotech industry.
• In-depth understanding of the healthcare regulatory environment and pharmaceutical compliance frameworks.
• Strong knowledge of Health Economics and Outcomes Research (HEOR).
• Ability to effectively present complex clinical and scientific information in varied professional settings.
• Proficiency in English, both oral and written.

Benefits

• Competitive base salary with eligibility for annual bonuses and annual equity awards.
• Comprehensive medical, dental, and vision benefits.
• Generous paid time off, including a week-long company shutdown in both Summer and Winter.
• Educational assistance programs, including student loan repayment support.
• 401(k) with company matching.
• Commuting subsidies and various wellbeing resources.

About the Company

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company focuses on treating the underlying causes of multiple chronic, life-shortening genetic diseases and maintains a robust clinical pipeline across various modalities.